Congo, Democratic Republic of the vs Mauritania: Hepatitis B surface antigen (HBsAg) prevalence
Congo, Democratic Republic of the
1.4%
in 2024
Mauritania
1.4%
in 2024
Congo, Democratic Republic of the rank
19th
Mauritania rank
19th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Congo, Democratic Republic of the
- Mauritania
How they compare
Congo, Democratic Republic of the currently reports 1.4% against 1.4% in Mauritania, a difference of 0.0%.
Across all 10 years both countries report, Mauritania has been ahead every year.
Congo, Democratic Republic of the ranks 19th and Mauritania ranks 19th of 194 countries.
Mauritania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 2.8% | 1.3% | Mauritania |
| 2020s | 1.4% | 1.6% | 0.2% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Congo, Democratic Republic of the or Mauritania?
- Congo, Democratic Republic of the, at 1.4% against 1.4% in Mauritania as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Congo, Democratic Republic of the and Mauritania?
- 0.0%, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Mauritania?
- 10 years are reported by both, from 2015 to 2024.
- How do Congo, Democratic Republic of the and Mauritania rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Congo, Democratic Republic of the ranks 19th and Mauritania ranks 19th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.